| Authors: |
Burkhart DL; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts., Morel KL; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts., Wadosky KM; Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York., Labbé DP; Division of Urology, Department of Surgery, McGill University and Research Institute of the McGill University Health Centre, Montréal, Québec, Canada., Galbo PM; Department of Cell Biology, Albert Einstein College of Medicine, New York, New York., Dalimov Z; State University of New York at Buffalo, Buffalo, New York., Xu B; Department of Pathology, Roswell Park Cancer Institute, Buffalo, New York., Loda M; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York., Ellis L; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. Leigh_Ellis@dfci.harvard.edu.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts. |
